Department of Pharmacy Sciences, School of Pharmacy & Health Professions, Creighton University, Omaha, NE 68178, USA.
Ther Deliv. 2021 Nov;12(11):775-788. doi: 10.4155/tde-2021-0054. Epub 2021 Nov 22.
A polymeric gelling delivery system for localized and sustained delivery to jawbone infections was developed. gelling delivery systems were prepared using either Poly(dl-lactic acid) or chitosan and Pluronic F127/Pluronic F68. Metronidazole nanoparticles were prepared using poly(dl-lactide-co-glycolide) or chitosan. Poly(dl-lactide-co-glycolide) was used for microparticles. Particles were characterized for size, charge and morphology. Viscosity and yield stress of the gels were 0.4 Pa.s and 2 Pa, respectively, with 70% cell viability over 72 h. Around 90% of loaded metronidazole was released at a sustained rate over 1 week. Use of appropriate amount of nano/microparticles in the gel resulted in a sustained release over a period of 1 week - needed for jawbone infection.
一种用于颌骨感染的局部和持续递药的聚合胶态输送系统被开发出来。胶态输送系统是使用聚(DL-丙交酯)或壳聚糖和泊洛沙姆 F127/泊洛沙姆 F68 制备的。甲硝唑纳米颗粒是使用聚(DL-丙交酯-共-乙交酯)或壳聚糖制备的。聚(DL-丙交酯-共-乙交酯)用于制备微球。对颗粒的粒径、电荷和形态进行了表征。凝胶的粘度和屈服应力分别为 0.4 Pa.s 和 2 Pa,72 h 内细胞活力保持在 70%以上。大约 90%的负载甲硝唑以持续速率释放超过 1 周。在凝胶中使用适量的纳米/微颗粒可实现长达 1 周的持续释放-这是颌骨感染所需要的。